BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 3, 2009
View Archived Issues
Escitalopram and tianepine show comparable efficacy in geriatric depression
Read More
QuatRx reports results from phase III Ophena trial in vulvovaginal atrophy
Read More
PET radioligand [18F]AZD-4694 displays favorable profile for detection of Abeta deposits
Read More
Merck Serono claims S1P1receptor antagonists for autoimmune and inflammatory disorders
Read More
Roche presents novel BTK inhibitors for the treatment of rheumatoid arthritis
Read More
University of Edinburgh reports new 11beta-HSD1 inhibitors
Read More
AstraZeneca developing new glucocorticoid receptor agonists for treatment of asthma
Read More
Plethora presents results for phase III PSD-502 trial in premature ejaculation
Read More
Neurocrine reports new 6-month data for elagolix in patients with endometriosis
Read More
Forma collaborates with Novartis on inhibitors of protein-protein interactions
Read More
GlaxoSmithKline withdraws MAA for Bosatria
Read More
OvPlex ovarian cancer diagnostic to be launched in the U.K. and Ireland
Read More
Lundbeck and Solvay discontinue development of bifeprunox in schizophrenia
Read More
Prima BioMed submits IND to FDA for CVac ovarian cancer therapy vaccine
Read More
Patient enrollment completed in phase IIb trial of HMPL-004 in UC
Read More
GenVec receives grant from NIAID to support malaria vaccine program
Read More
Anadys receives FDA clearance for phase II ANA-598 protocol
Read More
Phase II/III data support efficacy and tolerability of lurasidone in acute schizophrenia
Read More
Marplan shows potential in migraine prophylaxis in small open-label trial
Read More
Lopinavir/ritonavir has similar safety and efficacy in q.d. and b.i.d. dosing in HIV-1 patients
Read More
Jerini discloses preclinical data on its bradykinin B2 receptor antagonist JSM-10292
Read More
FDA approves Tyvaso inhalation solution for pulmonary arterial hypertension
Read More
AstraZeneca submits NDA and MAA for vandetanib in non-small cell lung cancer
Read More
Cytos reports phase II CYT003-QbG10 monotherapy results in dust mite allergy
Read More
Transave enters into agreement with NIH for Arikace in mycobacteria infections
Read More
